EFM
OLMA icon

E Fund Management’s Olema Pharmaceuticals OLMA Stock Holding History

E Fund Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$133K Sell
10,649
-5,884
-36% -$78.8K ﹤0.01% 468
2026
Q1 		$247K Buy
+16,533
New +$368K 0.01% 421
2024
Q2 		– Sell
-13,927
Closed -$158K – 356
2024
Q1 		$158K Buy
+13,927
New +$180K 0.01% 359

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

E Fund Management's OLMA Position: Q2 2026 in Review

E Fund Management reduced its Olema Pharmaceuticals (OLMA) stake by 36% in Q2 2026, selling an estimated $78.8K and leaving 10,649 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #468.

E Fund Management first reported a position in OLMA in Q1 2024 and has held it in 3 quarters since. The position peaked at $247K in Q1 2026. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • E Fund Management held 10,649 shares of Olema Pharmaceuticals worth $133K as of Q2 2026.
  • E Fund Management sold 5,884 Olema Pharmaceuticals shares in Q2 2026, an estimated $78.8K.
  • Olema Pharmaceuticals made up ﹤0.01% of E Fund Management's portfolio in Q2 2026, its #468 holding.
  • E Fund Management first reported a position in Olema Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • E Fund Management's Olema Pharmaceuticals position peaked at $247K in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.